TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7959281

Group type: EXPERIMENTAL
Intervention: Surgical stapling technique
Number of subjects: 15

Group type: COMPARATOR
Intervention: Traditional clamp, cut, and suture ligation technique
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 15
Study: 3304409

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 100 mg twice daily
Number of subjects: 38

Group type: COMPARATOR
Intervention: Routine postoperative therapy alone
Number of subjects: 38
Study: 31486230

Group type: EXPERIMENTAL
Intervention: Combination of canagliflozin (100 mg/d) and teneligliptin (20 mg/d)
Number of subjects: 99

Group type: COMPARATOR
Intervention: SGLT2 inhibitor monotherapy (canagliflozin 100 mg/d)
Number of subjects: 99
Study: 31198139

Group type: EXPERIMENTAL
Intervention: CPIS-guided therapy
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group (clinical experience of chief physician)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: CPIS group
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 166
Study: 28278354

Group type: EXPERIMENTAL
Intervention: Cerebellar anodal transcranial direct current stimulation (a‐tDCS) at 2 mA for 20 min
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham tDCS (tDCS turned off after 30 seconds)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cerebellar anodal transcranial direct current stimulation (a‐tDCS)
Number of subjects: 30
Study: 26686794

Group type: EXPERIMENTAL
Intervention: Cinacalcet in addition to conventional therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 0
Study: 23771841

Group type: EXPERIMENTAL
Intervention: Culturally specific pilot clinic for Asian Americans
Number of subjects: 109

Group type: COMPARATOR
Intervention: Standard care for white patients with type 2 diabetes
Number of subjects: 109
Study: 21649779

Group type: EXPERIMENTAL
Intervention: Steerable sheath (group S)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nonsteerable sheath (group NS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Patients with incomplete MI block
Number of subjects: 80

Group type: COMPARATOR
Intervention: Patients with achieved MI block
Number of subjects: 80
Study: 19674727

Group type: EXPERIMENTAL
Intervention: Staked-on syringe design
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Both syringe designs
Number of subjects: 464

Group type: COMPARATOR
Intervention: Luer cone syringe design
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Staked-on syringe design (after September 22, 2006)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Luer cone syringe design (after September 22, 2006)
Number of subjects: 464
Study: 16466610

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg/day
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg/day
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Pregabalin (all doses)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 370
Study: 15165384

Group type: EXPERIMENTAL
Intervention: Whirlpool and infrared GaAs diode laser with a frequency of 100 Hz applied between the 8th and 21st days postoperatively
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (laser instrument switched off during applications)
Number of subjects: 25
Study: 11303491

Group type: EXPERIMENTAL
Intervention: Low-variety (LV) diet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Medium-variety (MV) diet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-variety (HV) diet
Number of subjects: 12
Study: 9049555

Group type: EXPERIMENTAL
Intervention: Deep halothane anaesthesia (2% end-tidal concentration)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 1% halothane and suxamethonium anaesthesia
Number of subjects: 100
Study: 8325041

Group type: EXPERIMENTAL
Intervention: Rifaximin (1200 mg/day for 15 days)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Lactulose (30 g/day for 15 days)
Number of subjects: 58
Study: 3090597

Group type: EXPERIMENTAL
Intervention: 0.347 g/kg ethanol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.694 g/kg ethanol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 29226494

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) for problem gambling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Routine CBT treatments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exposure therapy for problem gambling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients of a gambling help service
Number of subjects: 0
Study: 26847318

Group type: COMPARATOR
Intervention: Therapeutic Exercise (TE)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Occupation Based Intervention (OBI) + Therapeutic Exercise (TE)
Number of subjects: 46
Study: 25703450

Group type: EXPERIMENTAL
Intervention: CGA-based care at the AGU in addition to usual care
Number of subjects: 382
Study: 24081236

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Low-protein diet
Number of subjects: 742

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Low-protein/low-GI diet
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Low-protein/high-GI diet
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: High-protein/low-GI diet
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: High-protein/high-GI diet
Number of subjects: 742
Study: 20500280

Group type: EXPERIMENTAL
Intervention: Clamped catheter group
Number of subjects: 113

Group type: COMPARATOR
Intervention: Free drainage group
Number of subjects: 113
Study: 17563996

Group type: EXPERIMENTAL
Intervention: Voluven (hydroxyethylstarch 130/0.4)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Dextrans
Number of subjects: 35
Study: 15068184

Group type: EXPERIMENTAL
Intervention: Active ankle-foot orthosis (AAFO) with variable impedance control
Number of subjects: 2

Group type: COMPARATOR
Intervention: Zero impedance control strategy
Number of subjects: 2

Group type: COMPARATOR
Intervention: Constant impedance control strategy
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Variable impedance control strategy
Number of subjects: 2
Study: 11414348

Group type: EXPERIMENTAL
Intervention: Treatment for alcohol and drug abuse
Number of subjects: 162
Study: 10021955

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 50
Study: 7826557

Group type: EXPERIMENTAL
Intervention: Low-sodium/high-potassium diet
Number of subjects: 587

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Low-sodium/high-potassium diet with chlorthalidone (25 mg/day)
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Low-sodium/high-potassium diet with atenolol (50 mg/day)
Number of subjects: 587

Group type: COMPARATOR
Intervention: Usual diet with chlorthalidone (25 mg/day)
Number of subjects: 587

Group type: COMPARATOR
Intervention: Usual diet with atenolol (50 mg/day)
Number of subjects: 587
Study: 3279101

Group type: EXPERIMENTAL
Intervention: Intravenous nutrient infusion containing amino acids (3.4 g/h), dextrose (20 g/h), and insulin (1.6 units/h)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravenous nutrient infusion containing amino acids, glucose, and insulin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard commercial mixture of amino acids
Number of subjects: 12
Study: 30901599

Group type: EXPERIMENTAL
Intervention: SNSI‐CHI (Chinese Version of the Student Nurse Stress Index Scale)
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: SNSI‐CHI
Number of subjects: 1100
Study: 28812392

Group type: EXPERIMENTAL
Intervention: Performing arts module of the DASH questionnaire
Number of subjects: 130

Group type: COMPARATOR
Intervention: General DASH questionnaire
Number of subjects: 130

Group type: COMPARATOR
Intervention: Pain disability index
Number of subjects: 130

Group type: COMPARATOR
Intervention: Short-Form 36
Number of subjects: 130

Group type: COMPARATOR
Intervention: Playing-related musculoskeletal disorder (PRMD) intensity
Number of subjects: 130

Group type: COMPARATOR
Intervention: Pain intensity
Number of subjects: 130
Study: 26815247

Group type: EXPERIMENTAL
Intervention: MILD procedure
Number of subjects: 302

Group type: COMPARATOR
Intervention: Epidural steroid injections (ESIs)
Number of subjects: 302
Study: 23404665

Group type: EXPERIMENTAL
Intervention: PROSPER intervention
Number of subjects: 317

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 317
Study: 22891287

Group type: EXPERIMENTAL
Intervention: Intramuscular route of subvirion inactivated influenza A virus subtype H5N1 vaccine (38.7 μg of H5N1 hemagglutinin)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Intradermal route of subvirion inactivated influenza A virus subtype H5N1 vaccine (38.7 μg of H5N1 hemagglutinin)
Number of subjects: 227
Study: 20472059

Group type: EXPERIMENTAL
Intervention: Biphasic dissolution testing with pH-gradient
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional dissolution testing at pH 1, pH 5.5, or pH 6.8
Number of subjects: 0
Study: 17483649

Group type: EXPERIMENTAL
Intervention: Oral risedronate 5 mg/day after the fifth postoperative day
Number of subjects: 46

Group type: COMPARATOR
Intervention: No drug treatment (Control)
Number of subjects: 46
Study: 15926385

Group type: EXPERIMENTAL
Intervention: Chhabra shunt
Number of subjects: 195

Group type: COMPARATOR
Intervention: Codman shunt
Number of subjects: 195
Study: 12070571

Group type: EXPERIMENTAL
Intervention: Magneto-treated blood autotransfusion
Number of subjects: 66
Study: 10475183

Group type: EXPERIMENTAL
Intervention: Daily application of a sun protection factor 15-plus sunscreen
Number of subjects: 1621

Group type: EXPERIMENTAL
Intervention: Betacarotene supplementation (30 mg per day)
Number of subjects: 1621

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1621

Group type: COMPARATOR
Intervention: Sunscreen plus placebo tablets
Number of subjects: 1621

Group type: COMPARATOR
Intervention: Betacarotene only
Number of subjects: 1621

Group type: COMPARATOR
Intervention: Placebo only
Number of subjects: 1621
Study: 8688975

Group type: EXPERIMENTAL
Intervention: Nonspecific hospital mattress
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: First foam mattress
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Second foam mattress
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Air mattress
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Water-filled mattress
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard mattress
Number of subjects: 20
Study: 1681778

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 7042206

Group type: EXPERIMENTAL
Intervention: Protocol group (median values of survivors as therapeutic goals)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (normal values of unstressed healthy volunteers as therapeutic goals)
Number of subjects: 100
Study: 30406509

Group type: EXPERIMENTAL
Intervention: Propolis 0.5%
Number of subjects: 397

Group type: COMPARATOR
Intervention: Aciclovir 5%
Number of subjects: 397
Study: 28818225

Group type: EXPERIMENTAL
Intervention: ACTitouch (AT) device
Number of subjects: 89

Group type: COMPARATOR
Intervention: Compression Stockings (CS)
Number of subjects: 89
Study: 25830400

Group type: EXPERIMENTAL
Intervention: Implant-supported fixed partial dentures (IFPDs)
Number of subjects: 12
Study: 23485949

Group type: EXPERIMENTAL
Intervention: 5‐HTR1B G861C genetic variant
Number of subjects: 387
Study: 22057411

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment based on identified CM patterns
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 16
Study: 18723297

Group type: EXPERIMENTAL
Intervention: Dose-escalated three-dimensional conformal radiotherapy (3D-CRT) at doses of 66, 72, 78, and 84 Gy with concurrent Carmustine 80 mg/m² during RT and every 8 weeks for 6 cycles
Number of subjects: 209
Study: 17526474

Group type: EXPERIMENTAL
Intervention: Laryngeal mask anesthesia (LMA) with fentanyl plus propofol
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with bupivacaine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (LMA)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (Spinal anesthesia)
Number of subjects: 46
Study: 15105283

Group type: EXPERIMENTAL
Intervention: B9340 (bradykinin receptor antagonist)
Number of subjects: 14
Study: 11251666

Group type: EXPERIMENTAL
Intervention: Fixed prostheses
Number of subjects: 48

Group type: COMPARATOR
Intervention: Removable overdenture
Number of subjects: 48
Study: 9613426

Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) feeding formulas
Number of subjects: 0

Group type: COMPARATOR
Intervention: Feeding without MCT
Number of subjects: 0
Study: 8580272

Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study: 2125839

Group type: EXPERIMENTAL
Intervention: Group 1 (imagery)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group 1 (imagery) and Group 2 (placebo controls) combined
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group 2 (placebo controls)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group 3 (control)
Number of subjects: 0
Study: 7220406

Group type: EXPERIMENTAL
Intervention: Erythromycin estolate preparation (500 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Erythromycin propionate preparation (500 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Erythromycin stearate preparation (500 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Comparison of serum and plasma concentrations
Number of subjects: 6
Study: 30171442

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 28547998

Group type: EXPERIMENTAL
Intervention: Omarigliptin 25 mg once weekly
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 26512041

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 23065731

Group type: EXPERIMENTAL
Intervention: Referral strategy 1 (any of inflammatory back pain (IBP), HLA‐B27 or sacroiliitis on imaging)
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Referral strategy 2 (two of the following: IBP, HLA‐B27, sacroiliitis, family history of axial SpA, good response to non‐steroidal anti‐inflammatory drugs, extra‐articular manifestations)
Number of subjects: 1072

Group type: COMPARATOR
Intervention: Comparison of both strategies
Number of subjects: 1072
Study: 21156068

Group type: EXPERIMENTAL
Intervention: 9 week intensive group behavioural support course
Number of subjects: 17

Group type: COMPARATOR
Intervention: 7 week brief advice only course
Number of subjects: 17
Study: 18398081

Group type: EXPERIMENTAL
Intervention: Omega-3 free fatty acids (4 g/d)
Number of subjects: 738

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 738
Study: 16618399

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 12582792

Group type: EXPERIMENTAL
Intervention: Injectable calcium phosphate bone cement (Norian SRS)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Percutaneous pinning and immobilisation in a cast for 6 weeks (Control)
Number of subjects: 52
Study: 10879638

Group type: EXPERIMENTAL
Intervention: 0.3% ofloxacin solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combination of fortified tobramycin (1.5%) and cefazolin (5%) solutions
Number of subjects: 30
Study: 8979380

Group type: EXPERIMENTAL
Intervention: Positive stereotypes of aging (subliminal activation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative stereotypes of aging (subliminal activation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Young individuals (control group)
Number of subjects: 0
Study: 1633050

Group type: EXPERIMENTAL
Intervention: Iopentol
Number of subjects: 200

Group type: COMPARATOR
Intervention: Metrizoate
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both media
Number of subjects: 200
Study: 6329004

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31493548

Group type: EXPERIMENTAL
Intervention: 3D model
Number of subjects: 102

Group type: COMPARATOR
Intervention: Textbook
Number of subjects: 102
Study: 30124525

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Good CPAP compliance
Number of subjects: 0
Study: 27038225

Group type: EXPERIMENTAL
Intervention: p-synephrine (3 mg kg(-1))
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 18
Study: 23281064

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham depletion (placebo)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Comparison of ATD relative to sham condition
Number of subjects: 10
Study: 22770575

Group type: EXPERIMENTAL
Intervention: Brinzolamide 1% plus timolol 0.5% suspension
Number of subjects: 62

Group type: COMPARATOR
Intervention: Dorzolamide 2% plus timolol 0.5% solution
Number of subjects: 62
Study: 21333194

Group type: EXPERIMENTAL
Intervention: Octyl‐cyanoacrylate tissue adhesive (OCT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard suture technique (4‐0 monocryl suture)
Number of subjects: 40
Study: 17992072

Group type: EXPERIMENTAL
Intervention: Hope intervention
Number of subjects: 40
Study: 17261962

Group type: EXPERIMENTAL
Intervention: CPB with Baxter Duraflo II heparin-coated circuits, high doses of aprotinin, and pre-CPB hemofiltration
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional CPB
Number of subjects: 27
Study: 15012843

Group type: EXPERIMENTAL
Intervention: Cognitive impairment group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Residential facility control
Number of subjects: 60

Group type: COMPARATOR
Intervention: Community control
Number of subjects: 60
Study: 11015085

Group type: EXPERIMENTAL
Intervention: Parathyroidectomy in patients with 3 degrees HPT
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Parathyroidectomy in patients with 2 degrees HPT
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Parathyroidectomy in patients with 1 degrees HPT
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (thyroid disease)
Number of subjects: 96
Study: 9553234

Group type: EXPERIMENTAL
Intervention: PCA buprenorphine (intravenous)
Number of subjects: 50

Group type: COMPARATOR
Intervention: PCA morphine
Number of subjects: 50
Study: 8094940

Group type: EXPERIMENTAL
Intervention: Meperidine 50-100 mg + midazolam 1-3 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fentanyl 50-100 micrograms + midazolam 1-3 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sufentanil 5-10 micrograms + midazolam 1-3 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alfentanil 150-300 micrograms + midazolam 1-3 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meperidine 50-100 mg + midazolam 1-3 mg (lower gastrointestinal patients)
Number of subjects: 0
Study: 3775255

Group type: EXPERIMENTAL
Intervention: Omeprazole, buffered solution, doses of 10-60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omeprazole, buffered solution
Number of subjects: 0
Study: 31552510

Group type: EXPERIMENTAL
Intervention: Combined exercise training (CET) - resistance and aerobic training three times a week for 16 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group - recreational activities twice a week for 16 weeks
Number of subjects: 23
Study: 30554821

Group type: EXPERIMENTAL
Intervention: E2: APA for 2 seconds/mm2-ethanol cleaned
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: E5: APA for 5 seconds/mm2-ethanol cleaned
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control: NT (no treatment)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: E10: APA for 10 seconds/mm2-ethanol cleaned
Number of subjects: 150
Study: 28606970

Group type: EXPERIMENTAL
Intervention: Tight Control (TC; 4 weekly review with therapy escalation if criteria not met)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Standard Care (SC; 12 weekly review)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Tight Control (TC) for participants with oligoarthritis
Number of subjects: 206

Group type: COMPARATOR
Intervention: Standard Care (SC) for participants with oligoarthritis
Number of subjects: 206
Study: 26804926

Group type: EXPERIMENTAL
Intervention: Pomegranate juice (PJ)
Number of subjects: 38
Study: 25051297

Group type: EXPERIMENTAL
Intervention: Exposure treatment at 08.00 a.m. (high cortisol group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Exposure treatment at 06.00 p.m. (low cortisol group)
Number of subjects: 60
Study: 22990062

Group type: COMPARATOR
Intervention: Monopolar transurethral resection of the prostate
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Bipolar transurethral resection of the prostate
Number of subjects: 136
Study: 18667099

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT) plus treatment as usual (TAU)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 52
Study: 17315156

Group type: EXPERIMENTAL
Intervention: Decitabine
Number of subjects: 491

Group type: COMPARATOR
Intervention: Intensive chemotherapy (Group A)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Intensive chemotherapy (Group B)
Number of subjects: 491
Study: 15357159

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate dressing
Number of subjects: 0
Study: 11593871

Group type: EXPERIMENTAL
Intervention: Propofol-MCT/LCT 1% (Propofol-Lipuro)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol-LCT 1% (Disoprivan)
Number of subjects: 40
Study: 9673472

Group type: EXPERIMENTAL
Intervention: 0.5% betaxolol HCI, twice-daily bilateral topical ocular dosing for one year
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.5% betaxolol HCI
Number of subjects: 18
Study: 8045971

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10